HCV RAS Testing in Public Health Programs (RAS-HCV)
Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct Acting Antiviral Agents in the Public Health Setting
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
A observational or N/A phase clinical study on Direct Acting Antiviral Agents and Hepatitis C, this trial is ongoing. The trial is conducted by Post Graduate Institute of Medical Education and Research, Chandigarh and has accumulated 10 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Jul 2025 — Present [monthly]
Unknown
-
Sep 2024 — Jul 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2024 — Jul 2024 [monthly]
Unknown Status
-
Apr 2024 — May 2024 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
Jan 2022 — Apr 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Post Graduate Institute of Medical Education and Research, Chandigarh
For direct contact, visit the study record on ClinicalTrials.gov .